tiprankstipranks
Trending News
More News >
Alibaba Health Information Technology Ltd. (ALBHF)
OTHER OTC:ALBHF
US Market

Alibaba Health Information Technology (ALBHF) Stock Forecast & Price Target

Compare
344 Followers
See the Price Targets and Ratings of:

ALBHF Analyst Ratings

Moderate Buy
6Ratings
Moderate Buy
3 Buy
2 Hold
1 Sell
Based on 6 analysts giving stock ratings to
Alibaba
Health Information Technology
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ALBHF Stock 12 Month Forecast

Average Price Target

$0.75
▲(10.29% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for Alibaba Health Information Technology in the last 3 months. The average price target is $0.75 with a high forecast of $0.91 and a low forecast of $0.59. The average price target represents a 10.29% change from the last price of $0.68.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","1":"$1","-1":"-$1","-0.5":"-$0.5","0.5":"$0.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":0.9126269,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$0.91</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$0.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.5912794,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$0.59</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.5,0,0.5,1],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.71,0.7255866846153846,0.7411733692307692,0.7567600538461539,0.7723467384615385,0.787933423076923,0.8035201076923076,0.8191067923076923,0.8346934769230769,0.8502801615384615,0.8658668461538461,0.8814535307692308,0.8970402153846154,{"y":0.9126269,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.71,0.713076923076923,0.7161538461538461,0.7192307692307692,0.7223076923076923,0.7253846153846154,0.7284615384615385,0.7315384615384615,0.7346153846153846,0.7376923076923076,0.7407692307692307,0.7438461538461538,0.7469230769230769,{"y":0.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.71,0.7008676461538461,0.6917352923076923,0.6826029384615384,0.6734705846153846,0.6643382307692307,0.6552058769230769,0.646073523076923,0.6369411692307693,0.6278088153846154,0.6186764615384616,0.6095441076923077,0.6004117538461539,{"y":0.5912794,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.4,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.64,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.51,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.51,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.6,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.56,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.66,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.54,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.6,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.67,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.83,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.75,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.71,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$0.91Average Price Target$0.75Lowest Price Target$0.59
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on ALBHF
Morgan Stanley
Morgan Stanley
$0.54$0.59
Sell
-13.05%
Downside
Reiterated
12/12/25
Cautious Stance on Alibaba Health: Sell Rating Amid Limited Upside Potential
Goldman Sachs Analyst forecast on ALBHF
Goldman Sachs
Goldman Sachs
$0.6$0.67
Hold
-1.71%
Downside
Reiterated
12/03/25
Analysts Conflicted on These Healthcare Names: Merck & Company (NYSE: MRK), Alibaba Health Information Technology (Other OTC: ALBHF) and Janux Therapeutics Inc (NASDAQ: JANX)
Guotai Haitong Analyst forecast on ALBHF
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
$0.73
Buy
7.56%
Upside
Reiterated
12/03/25
Alibaba Health Information Technology (ALBHF) Gets a Buy from Guotai Haitong
Huatai Securities Analyst forecast on ALBHF
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
$0.78
Buy
14.93%
Upside
Reiterated
11/30/25
Huatai Securities Remains a Buy on Alibaba Health Information Technology (ALBHF)
CICC Analyst forecast on ALBHF
Unknown Analyst
CICC
Not Ranked
CICC
$0.91
Buy
34.21%
Upside
Reiterated
11/28/25
Alibaba Health Information Technology (ALBHF) Gets a Buy from CICC
J.P. Morgan Analyst forecast on ALBHF
J.P. Morgan
J.P. Morgan
$0.64$0.84
Hold
22.87%
Upside
Reiterated
09/17/25
Alibaba Health Information Technology (ALBHF) Receives a Hold from J.P. MorganJPMorgan analyst Alex Yao raised the price target on Alibaba Health (241:HK) (NYSE: BABA) to HK$6.50 (from HK$5.00) while maintaining a Neutral rating.
Macquarie Analyst forecast on ALBHF
Macquarie
Macquarie
$0.44$0.87
Buy
28.16%
Upside
Upgraded
08/19/25
Positive Report for Alibaba Health Information Technology (ALBHF) from Macquarie
Citi
$1.09
Buy
60.67%
Upside
Reiterated
07/04/25
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (NASDAQ: HRMY) and Alibaba Health Information Technology (Other OTC: ALBHF)
Huatai Securities Analyst forecast on ALBHF
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
$0.7
Buy
2.64%
Upside
Reiterated
05/21/25
UOB Kay Hian Analyst forecast on ALBHF
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
$0.9$0.8
Buy
17.20%
Upside
Reiterated
05/21/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on ALBHF
Morgan Stanley
Morgan Stanley
$0.54$0.59
Sell
-13.05%
Downside
Reiterated
12/12/25
Cautious Stance on Alibaba Health: Sell Rating Amid Limited Upside Potential
Goldman Sachs Analyst forecast on ALBHF
Goldman Sachs
Goldman Sachs
$0.6$0.67
Hold
-1.71%
Downside
Reiterated
12/03/25
Analysts Conflicted on These Healthcare Names: Merck & Company (NYSE: MRK), Alibaba Health Information Technology (Other OTC: ALBHF) and Janux Therapeutics Inc (NASDAQ: JANX)
Guotai Haitong Analyst forecast on ALBHF
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
$0.73
Buy
7.56%
Upside
Reiterated
12/03/25
Alibaba Health Information Technology (ALBHF) Gets a Buy from Guotai Haitong
Huatai Securities Analyst forecast on ALBHF
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
$0.78
Buy
14.93%
Upside
Reiterated
11/30/25
Huatai Securities Remains a Buy on Alibaba Health Information Technology (ALBHF)
CICC Analyst forecast on ALBHF
Unknown Analyst
CICC
Not Ranked
CICC
$0.91
Buy
34.21%
Upside
Reiterated
11/28/25
Alibaba Health Information Technology (ALBHF) Gets a Buy from CICC
J.P. Morgan Analyst forecast on ALBHF
J.P. Morgan
J.P. Morgan
$0.64$0.84
Hold
22.87%
Upside
Reiterated
09/17/25
Alibaba Health Information Technology (ALBHF) Receives a Hold from J.P. MorganJPMorgan analyst Alex Yao raised the price target on Alibaba Health (241:HK) (NYSE: BABA) to HK$6.50 (from HK$5.00) while maintaining a Neutral rating.
Macquarie Analyst forecast on ALBHF
Macquarie
Macquarie
$0.44$0.87
Buy
28.16%
Upside
Upgraded
08/19/25
Positive Report for Alibaba Health Information Technology (ALBHF) from Macquarie
Citi
$1.09
Buy
60.67%
Upside
Reiterated
07/04/25
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (NASDAQ: HRMY) and Alibaba Health Information Technology (Other OTC: ALBHF)
Huatai Securities Analyst forecast on ALBHF
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
$0.7
Buy
2.64%
Upside
Reiterated
05/21/25
UOB Kay Hian Analyst forecast on ALBHF
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
$0.9$0.8
Buy
17.20%
Upside
Reiterated
05/21/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Alibaba Health Information Technology

1 Month
xxx
Success Rate
3/5 ratings generated profit
60%
Average Return
+5.90%
upgraded a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of +5.90% per trade.
3 Months
xxx
Success Rate
1/2 ratings generated profit
50%
Average Return
+7.75%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +7.75% per trade.
1 Year
Alexis YanMorgan Stanley
Success Rate
1/2 ratings generated profit
50%
Average Return
+7.75%
reiterated a sell rating 5 days ago
Copying Alexis Yan's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +7.75% per trade.
2 Years
xxx
Success Rate
1/2 ratings generated profit
50%
Average Return
+7.75%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +7.75% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ALBHF Analyst Recommendation Trends

Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
3
3
2
1
2
Buy
0
0
0
0
0
Hold
2
1
6
6
6
Sell
1
0
0
1
2
Strong Sell
0
0
0
0
0
total
6
4
8
8
10
In the current month, ALBHF has received 2 Buy Ratings, 6 Hold Ratings, and 2 Sell Ratings. ALBHF average Analyst price target in the past 3 months is 0.75.
Each month's total comprises the sum of three months' worth of ratings.

ALBHF Financial Forecast

ALBHF Earnings Forecast

Next quarter’s earnings estimate for ALBHF is <$0.01 with a range of <$0.01 to <$0.01. The previous quarter’s EPS was $0.01. ALBHF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year ALBHF has Performed in-line its overall industry.
Next quarter’s earnings estimate for ALBHF is <$0.01 with a range of <$0.01 to <$0.01. The previous quarter’s EPS was $0.01. ALBHF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year ALBHF has Performed in-line its overall industry.

ALBHF Sales Forecast

Next quarter’s sales forecast for ALBHF is $2.63B with a range of $2.61B to $2.66B. The previous quarter’s sales results were $2.33B. ALBHF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year ALBHF has Performed in-line its overall industry.
Next quarter’s sales forecast for ALBHF is $2.63B with a range of $2.61B to $2.66B. The previous quarter’s sales results were $2.33B. ALBHF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year ALBHF has Performed in-line its overall industry.

ALBHF Stock Forecast FAQ

What is ALBHF’s average 12-month price target, according to analysts?
Based on analyst ratings, Alibaba Health Information Technology Ltd.’s 12-month average price target is 0.75.
    What is ALBHF’s upside potential, based on the analysts’ average price target?
    Alibaba Health Information Technology Ltd. has 10.29% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ALBHF a Buy, Sell or Hold?
          Alibaba Health Information Technology Ltd. has a consensus rating of Moderate Buy which is based on 3 buy ratings, 2 hold ratings and 1 sell ratings.
            What is Alibaba Health Information Technology Ltd.’s price target?
            The average price target for Alibaba Health Information Technology Ltd. is 0.75. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $0.91 ,the lowest forecast is $0.59. The average price target represents 10.29% Increase from the current price of $0.68.
              What do analysts say about Alibaba Health Information Technology Ltd.?
              Alibaba Health Information Technology Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.
                How can I buy shares of ALBHF?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.